Cost-effectiveness analysis of carrier and prenatal genetic testing for X-linked hemophilia.

Main|Search|PHGKB

From Genomics & Health Impact Scan Database

This database includes published scientific literature on evidence-based translation of genomic discoveries into improved health care and disease prevention that have a potential impact on population health.

---

• Cost-effectiveness analysis of carrier and prenatal genetic testing for X-linked hemophilia.  
  Tsai MC, et al. Journal of the Formosan Medical Association = Taiwan yi zhi 2013 8
• Genetic testing in patients with acute coronary syndrome undergoing percutaneous coronary intervention: a cost-effectiveness analysis.  
  Lala A, et al. Journal of thrombosis and haemostasis : JTH 2013 1 (1) 1
• Newborn screening by tandem mass spectrometry for glutaric aciduria type 1: a cost-effectiveness analysis.  
  Pfeil J, et al. Orphanet journal of rare diseases 2013 1
• Gene expression profiling and expanded immunohistochemistry tests to guide the use of adjuvant chemotherapy in breast cancer management: a systematic review and cost-effectiveness analysis.  
  Ward S, et al. Health technology assessment (Winchester, England) 2013 10 (44) 44
• Cost-effectiveness analysis of universal newborn screening for medium chain acyl-CoA dehydrogenase deficiency in France.  
  Hamers FF, et al. BMC pediatrics 2012 9

more